XORTX Therapeutics IncXRTX
Price$1.69

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $27.4K-3.1% YoYTTM through 31 Dec 2021
Net Income -$1.3MTTM through 31 Dec 2021
Free Cash Flow -$6.1MTTM through 31 Dec 2021

Margins

Current
Gross Margin0.0%
Operating Margin-11,914.7%
Net Margin-4,727.6%

Returns

-127.4%ROE
-99.0%ROA

Balance Sheet Health

Debt / Equity0.04x
Current Ratio2.11x
Net Debt-$784Knet cash position
Cash & Equivalents$18.9M

Quality Metrics

FCF Margin-22,163.3%
Earnings-Beat Rate100.0%

Dividend

No dividend

Segment Performance

No segment data available.

Financials converted at 1.2744.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.